Zacks Investment Research on MSN
OCGN gene-agnostic eye therapy could shift retinal drug development
Ocugen OCGN is building its ocular portfolio around a modifier gene therapy idea: instead of designing a therapy for a single genetic defect, the platform is intended to work across many underlying ...
Modifier -73 — CPT guidelines state that the physician may cancel a surgical or diagnostic procedure subsequent to the patient’s surgical preparation (including sedation when provided, and being taken ...
Blue Cross Blue Shield Michigan has clarified their policy surrounding a modifier applied to certain outpatient surgical codes. In February, BCBS Michigan released a new reimbursement policy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results